M Robinson, JA Regnis, DL Bailey, M King, GJ Bautovich and PT Bye
Respiratory Investigation Unit, Royal Prince Alfred Hospital, Sydney, Australia.

In patients with cystic fibrosis (CF), dehydration of airway secretions leads to a decrease in mucociliary clearance (MCC). We examined the acute effect of MCC of a single administration by aerosolization of hypertonic saline (7%) (HS), amiloride (0.3% in 0.12% NaCl) (AML) and a combination of AML and HS (AML + HS) in 12 patients with CF using a radioaerosol technique. Isotonic saline [0.9%] (IS) was used as a control solution. As both the AML and HS solutions induced cough in some patients, the last nine patients studied also underwent a cough clearance day. This was to eliminate the possible confounding effect of cough on MCC measurement. Patients ranged from 18 to 28 yr (mean +/- SD, 22 +/- 3) with an FEV1 of 27 to 112% predicted (61 +/- 30%). Following deposition of the radioaerosol, baseline clearance was assessed for 30 min. This was followed by a 30-min intervention period. Assessment of post-intervention clearance for a further 30 min was then performed. Comparison of the amount of radioaerosol cleared from the right lung was made at 60 min (%C60) and 90 min (%C90) using repeated measures ANOVA. The percent cleared at 60 and 90 min was significantly increased with HS (%C60 = 26.5%, %C90 = 29.4%) and the combination of AML + HS (%C60 = 23.1%, %C90 = 27.4%) compared with both IS (%C60 = 14.7%, %C90 = 17.5%) and COUGH (%C60 = 18.0%, %C90 = 19.5%), p < 0.01. Inhalation of hypertonic saline is a potentially useful treatment in patients with cystic fibrosis.

This article has been cited by other articles:

				A. Jaques, E. Daviskas, J. A. Turton, K. McKay, P. Cooper, R. G. Stirling, C. F. Robertson, P. T. P. Bye, P. N. LeSouef, B. Shadbolt, et al. Inhaled Mannitol Improves Lung Function in Cystic Fibrosis Chest, June 1, 2008; 133(6): 1388 - 1396. [Abstract] [Full Text] [PDF]

				M. D. Carattino, C. J. Passero, C. A. Steren, A. B. Maarouf, J. M. Pilewski, M. M. Myerburg, R. P. Hughey, and T. R. Kleyman Defining an inhibitory domain in the {alpha}-subunit of the epithelial sodium channel Am J Physiol Renal Physiol, January 1, 2008; 294(1): F47 - F52. [Abstract] [Full Text] [PDF]

				S. H. Donaldson, T. E. Corcoran, B. L. Laube, and W. D. Bennett Mucociliary Clearance as an Outcome Measure for Cystic Fibrosis Clinical Research Proceedings of the ATS, August 1, 2007; 4(4): 399 - 405. [Abstract] [Full Text] [PDF]

				S. C Bell and P. J Robinson Exacerbations in cystic fibrosis: 2 {middle dot} Prevention Thorax, August 1, 2007; 62(8): 723 - 732. [Abstract] [Full Text] [PDF]

				B. Enderby and I. Doull Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success? Arch. Dis. Child., March 1, 2007; 92(3): 195 - 196. [Full Text] [PDF]

				L. M Taylor and R. J Kuhn Hypertonic Saline Treatment of Cystic Fibrosis Ann. Pharmacother., March 1, 2007; 41(3): 481 - 484. [Abstract] [Full Text] [PDF]

				M. H. Levin, S. Sullivan, D. Nielson, B. Yang, W. E. Finkbeiner, and A. S. Verkman Hypertonic Saline Therapy in Cystic Fibrosis: EVIDENCE AGAINST THE PROPOSED MECHANISM INVOLVING AQUAPORINS J. Biol. Chem., September 1, 2006; 281(35): 25803 - 25812. [Abstract] [Full Text] [PDF]

				M. R. Elkins, M. Robinson, B. R. Rose, C. Harbour, C. P. Moriarty, G. B. Marks, E. G. Belousova, W. Xuan, P. T.P. Bye, and the National Hypertonic Saline in Cystic Fibrosis A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis N. Engl. J. Med., January 19, 2006; 354(3): 229 - 240. [Abstract] [Full Text] [PDF]

				S. H. Donaldson, W. D. Bennett, K. L. Zeman, M. R. Knowles, R. Tarran, and R. C. Boucher Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline N. Engl. J. Med., January 19, 2006; 354(3): 241 - 250. [Abstract] [Full Text] [PDF]

				R.C. Boucher New concepts of the pathogenesis of cystic fibrosis lung disease Eur. Respir. J., January 1, 2004; 23(1): 146 - 158. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]

				C. Kishioka, K. Okamoto, J.-S. Kim, and B. K. Rubin Hyperosmolar Solutions Stimulate Mucus Secretion in the Ferret Trachea Chest, July 1, 2003; 124(1): 306 - 313. [Abstract] [Full Text] [PDF]

				M. L. Aitken, K. E. Greene, M. R. Tonelli, J. L. Burns, J. C. Emerson, C. H. Goss, and R. L. Gibson Analysis of Sequential Aliquots of Hypertonic Saline Solution-Induced Sputum From Clinically Stable Patients With Cystic Fibrosis Chest, March 1, 2003; 123(3): 792 - 799. [Abstract] [Full Text] [PDF]

				A. Mandelberg, G. Tal, M. Witzling, E. Someck, S. Houri, A. Balin, and I. E. Priel Nebulized 3% Hypertonic Saline Solution Treatment in Hospitalized Infants With Viral Bronchiolitis Chest, February 1, 2003; 123(2): 481 - 487. [Abstract] [Full Text] [PDF]

				N. Sood, W. D. Bennett, K. Zeman, J. Brown, C. Foy, R. C. Boucher, and M. R. Knowles Increasing Concentration of Inhaled Saline with or without Amiloride: Effect on Mucociliary Clearance in Normal Subjects Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 158 - 163. [Abstract] [Full Text] [PDF]

				E. Daviskas, S.D. Anderson, S. Eberl, H-K. Chan, I.H. Young, and J.P. Seale Effects of terbutaline in combination with mannitol on mucociliary clearance Eur. Respir. J., December 1, 2002; 20(6): 1423 - 1429. [Abstract] [Full Text] [PDF]

				E. M. Sarrell, G. Tal, M. Witzling, E. Someck, S. Houri, H. A. Cohen, and A. Mandelberg Nebulized 3% Hypertonic Saline Solution Treatment in Ambulatory Children With Viral Bronchiolitis Decreases Symptoms Chest, December 1, 2002; 122(6): 2015 - 2020. [Abstract] [Full Text] [PDF]

				C F Robertson How do we choose a therapeutic regimen in cystic fibrosis? Thorax, October 1, 2002; 57(10): 839 - 840. [Full Text] [PDF]

				R. Suri, L. J. Marshall, C. Wallis, C. Metcalfe, A. Bush, and J. K. Shute Effects of Recombinant Human DNase and Hypertonic Saline on Airway Inflammation in Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 352 - 355. [Abstract] [Full Text] [PDF]

				N R Henig, M R Tonelli, M V Pier, J L Burns, and M L Aitken Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis Thorax, April 1, 2001; 56(4): 306 - 311. [Abstract] [Full Text]

				E. Daviskas, S. D. Anderson, S. Eberl, H-K. Chan, and I. H. Young The 24-h Effect of Mannitol on the Clearance of Mucus in Patients With Bronchiectasis Chest, February 1, 2001; 119(2): 414 - 421. [Abstract] [Full Text] [PDF]

				N. SOOD, L. J. PARADOWSKI, and J. R. YANKASKAS Outcomes of Intensive Care Unit Care in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 335 - 338. [Abstract] [Full Text]

				J. Zabner, M. P. Seiler, J. L. Launspach, P. H. Karp, W. R. Kearney, D. C. Look, J. J. Smith, and M. J. Welsh The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing PNAS, October 10, 2000; 97(21): 11614 - 11619. [Abstract] [Full Text] [PDF]

				E. DAVISKAS, S. D. ANDERSON, S. EBERL, H-K. CHAN, and G. BAUTOVICH Inhalation of Dry Powder Mannitol Improves Clearance of Mucus in Patients with Bronchiectasis Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1843 - 1848. [Abstract] [Full Text]

				T. HOFMANN, M. J. STUTTS, A. ZIERSCH, C. RUCKES, W. M. WEBER, M. R. KNOWLES, H. LINDEMANN, and R. C. BOUCHER Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1844 - 1849. [Abstract] [Full Text] [PDF]

				M. KING, B. DASGUPTA, R. P. TOMKIEWICZ, and N. E. BROWN Rheology of Cystic Fibrosis Sputum after in vitro Treatment with Hypertonic Saline Alone and in Combination with Recombinant Human Deoxyribonuclease I Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 173 - 177. [Abstract] [Full Text]